Related Experiment Videos
Anticoagulation in the elderly
Abhay J Dhond1, Hector I Michelena, Michael D Ezekowitz
1Department of Medicine, Drexel University College of Medicine, Philadelphia, PA 19102, USA.
Insights
This review details anticoagulation management for elderly patients, focusing on nonvalvular atrial fibrillation. It emphasizes maximizing benefits and minimizing risks for those over 75 at high stroke risk.
Area of Science:
- Geriatric Medicine
- Cardiology
- Pharmacology
Background:
- Elderly patients represent a rapidly growing demographic with increased risk of thromboembolic events.
- Anticoagulation is crucial for managing conditions like nonvalvular atrial fibrillation and post-myocardial infarction.
- Optimal anticoagulation strategies in the elderly are essential to balance efficacy and safety.
Purpose of the Study:
- To outline a practical clinical approach for managing anticoagulation in elderly patients.
- To highlight strategies for maximizing therapeutic benefits while minimizing bleeding risks.
- To address the specific needs of patients aged 75 and older, who are at highest risk for stroke.
Main Methods:
- Review of data from clinical trials, primarily focusing on nonvalvular atrial fibrillation.
- Inclusion of data from post-myocardial infarction studies.
- Synthesis of evidence to formulate a practical management guideline.
Main Results:
- Anticoagulation offers significant stroke risk reduction in elderly patients.
- Careful patient selection and monitoring are key to optimizing outcomes.
- Risk stratification is crucial for tailoring anticoagulation therapy.
Conclusions:
- A tailored approach to anticoagulation is necessary for elderly patients.
- Maximizing benefits requires vigilant risk assessment and management.
- Effective anticoagulation strategies can significantly improve outcomes in older adults at high risk for stroke.
Abstract:
This review will address the general approach to the management of the typical elderly patient requiring anticoagulation. Most of the data has been derived from studies of patients with nonvalvular atrial fibrillation. Data from postmyocardial infarction trials have also been included. A practical clinical approach to anticoagulation in the elderly is described. Emphasis has been placed on maximizing the benefit and reducing the risk of anticoagulation in the rapidly expanding group of elderly patients aged >/=75 who are at the greatest risk of stroke and are likely to benefit the most from antithrombotic therapy.